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Abstract
Background: Mesenchymal stem cells (MSCs) can be induced to differentiate into neuronal cells under appropriate
cellular conditions and transplanted in brain injury and neurodegenerative diseases animal models for
neuroregeneration studies. In contrast to the embryonic stem cells (ESCs), MSCs are easily subject to aging and
senescence because of their finite ability of self-renewal. MSCs senescence seriously affected theirs application
prospects as a promising tool for cell-based regenerative medicine and tissue engineering. In the present study, we
established a reversible immortalized mesenchymal stem cells (IMSCs) line by using SSR#69 retrovirus expressing
simian virus 40 large T (SV40T) antigen as an alternative to primary MSCs.
Methods: The retroviral vector SSR#69 expressing simian virus 40 large T (SV40T) antigen was used to construct
IMSCs. IMSCs were identified by flow cytometry to detect cell surface makers. To investigate proliferation and
differentiation potential of IMSCs, cell growth curve determination and mesodermal trilineage differentiation tests
were performed. Neuronal differentiation characteristics of IMSCs were detected in vitro. Before IMSCs
transplantation, we excluded its tumorigenicity in nude mice firstly. The Morris water maze tests and shuttle box
tests were performed five weeks after HIBD models received cells transplantation therapy.
Results: In this study, reversible IMSCs were constructed successfully and had the similar morphology and cell
surface makers as primary MSCs. IMSCs possessed better ability of proliferation and anti-senescence compared with
primary MSCs, while maintained multilineage differentiation capacity. Neural-like cells derived from IMSCs had
similar expressions of neural-specific genes, protein expression patterns and resting membrane potential (RMP)
compared with their counterparts derived from primary MSCs. There was no bump formation in nude mice
subcutaneously injected with IMSCs. IMSCs played same role as primary MSCs to improve learning ability and
spatial memory of HIBD rats.
Conclusions: IMSCs not only retain their features of primary MSCs but also possess the ability of high proliferation
and anti-senescence. IMSCs can definitely be induced to differentiate into neuronal cells in vitro and take the place
of primary MSCs for cell transplantation therapy without tumorigenesis in vivo. The stable cell line is particularly
useful and valuable as an alternative to MSCs in neuronal differentiation and neuroregeneration associated studies.
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Mesenchymal stem cells (MSCs) are adult stem cells
present in many tissues, such as bone marrow, adipose
tissue and peripheral blood. They are able to differenti-
ate into multiple mesodermal lineage cells, such as
osteocytes, chondrocytes and adipocytes [1,2]. However,
recent studies have demonstrated that MSCs have the
ability to transdifferentiate across embryonic boundaries
[3,4] and be induced to differentiate into nonmesoder-
mal cells such as hepatocytes [5], endothelial cells [6]
and neuronal cells [7,8] under appropriate environmen-
tal conditions both in vitro and in vivo. Our previous
studies have clearly demonstrated that MSCs can be
induced to differentiate into neuronal cells [9] and be
used to improve neurological function in animal models
of hypoxic-ischemic brain damage (HIBD) by cell trans-
plantation therapy [10].
In contrast to the embryonic stem cells (ESCs) which
derive from blastocyst early-stage embryos and possess
an infinite capacity of self-renewal [11], MSCs have to
be subject to aging and senescence as the gradual degra-
dation of their replication ability [12]. Senescent MSCs
have very typical morphological characteristics. They
become flat, big and hypertrophic and reduce adhesion
to plastic surfaces. Because of lipofuscin accumulation,
autofluorescence level of senescent MSCs will increase.
And then, they present constrained nuclei, granular
cytoplasm and much cellular debris [13]. The prolifera-
tion ability and capacity to differentiate into various
types of cells seems to decrease due to senescence.
Although the underlying molecular mechanism of MSCs
senescence is currently unclear, recent studies indicated
that telomeres length [14], telomerase activity [15],
extracellular signal-regulated kinases (ERK) signaling
[16], TGF-b superfamily [17] and oxidative stress [18]
were involved in MSCs senescence. MSCs senescence
seriously affected its application prospects as a promis-
ing tool for cell-based regenerative medicine and tissue
engineering. Therefore, it is a challenge in MSCs
research to develop techniques for obtaining a sufficient
number of MSCs out of limited passages and avoiding
cell senescence.
In the present study, we infected primary MSCs with
retrovirus that express simian virus 40 large T (SV40T)
antigen to construct an immortalized mesenchymal
stem cells (IMSCs) line. We found that the morphology
and surface makers of high-passage IMSCs were the
same as that of primary MSCs. The proliferation capa-
city of IMSCs is stronger than that of primary MSCs,
meanwhile IMSCs maintained the mesodermal trilineage
differentiation potentials. In the further neuronal differ-
entiation research, we found that IMSCs had similar dif-
ferentiation ability and maturation time pattern
compared with primary MSCs and could be
transplanted into brain injury animal models to improve
its neurological function without tumor oncogenesis. In
general, our data suggest that IMSCs might be a good
and valuable alternative to MSCs in neural studies both
in vitro and in vivo.
Materials and methods
Isolation and expansion of rat primary mesenchymal
stem cells
R a tp r i m a r yM S C sw e r ei s o l a t e da n de x p a n d e da s
described before [9]. In brief, after the sacrifice of 4-
week-old Sprague Dawley (SD) rats, the tibias and
femurs were removed and cleaned of connective and
soft tissues. Bone marrow was flushed out of the cut
bones after removal of the epiphysis. Cells were cultured
in Dulbecco’s modified Eagle medium/Ham’sN u t r i e n t
Mixture F12 (DMEM/F12; Gibico) supplemented with
10% fetal bovine serum (FBS; Gibico), 100 units/ml
penicillin, and 100 μg/ml streptomycin at 37°C in a
humidified incubator containing 5% CO2. Cells were
digested with trypsin (Inv i t r o g e n )a n dp a s s a g e da t
approximately 90% confluence every 3-4 days. Cells
between passages three and six were used for subse-
quent experiments.
Flow cytometry
Cultured cells were trypsinized and resuspended in PBS
containing 1% bovine serum albumin (BSA). Cell sus-
pensions were incubated with different antibodies
including CD34-FITC (Santa Cruz), CD29-FITC (BD
Biosciences), CD44-FITC (Santa Cruz), CD45-PE (Biole-
gend), CD90-PE (Biolegend), and CD106-PE (BD Bios-
ciences) at recommended dilution for 30 min at room
temperature in the dark. After washed with PBS twice,
labeled cells were analyzed by FACSC-anto II system
(BD Biosciences) and quantified by using CellQuest Pro
software (BD Biosciences).
Construction of reversible immortalized mesenchymal
stem cells
The retroviral vector SSR#69 that expresses SV40T anti-
gen and hygromycin resistant gene flanked with loxP
sites [19] and package vector pAmpho were co-trans-
fected into human embryonic kidney 293 (HEK293) cell
lines by using LipfectMINE 2000 to package retrovirus
expressing SV40T antigen. Freshly isolated MSCs were
seeded in T25 flask and infected with 2 mL of filtered
retrovirus containing 4 μg/ml polybrene. After two days
infection, MSCs were selected in the presence of 0.4
mg/ml hygromycin B (Invitrogen) for 14 days, colonies
of selected MSCs emerged. Then the pool stable cell
lines designed as immortalized mesenchymal stem cells
(IMSCs) were expanded and frozen in liquid nitrogen
tanks. The reversal of IMSCs was achieved by
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fic Cre/loxP recombination. After infection with Ad-Cre
for 48 h, western blotting was carried out to confirm
SV40T was excised.
Cell growth curve of primary mesenchymal stem cells and
immortalized mesenchymal stem cells
Primary MSCs at passage 3 and IMSCs at passage 40 (7.5
×1 0
4 per well) were inoculated into 6-well culture plates
and incubated with complete DMEM/F12. Cells were tryp-
sinized and counted with Trypan Blue exclusion assay
(Sigma-Aldrich) as described [20] at 1, 2, 3, 4, 5 d after
inoculation, respectively. Briefly, cell suspension was
mixed with 2 × Trypan Blue solution. And then 10 μlo f
suspension mixture was added into hemocytometer and
viable cells exclude trypan blue were counted twice under
an inverted microscope (TE2000-S; Nikon). Three differ-
ent independent experiments were executed in duplicate.
Osteogenic differentiation, adipogenic differentiation and
chondrogenic differentiation of primary mesenchymal
stem cells and immortalized mesenchymal stem cells
Cells were seeded and grown to approximately 70-80%
confluence in 6-well culture plates. To initiate trilineage
differentiation, complete DMEM⁄ F12 medium was
removed, and tissue-specific differentiation medium was
added and maintained for three weeks as described
[21-23]. Concretely, osteogenic induction medium
(Hyclone) was added to induce osteogenic differentiation
and subsequently changed every 3-4 days. Three weeks
later, cells were fixed in methanol at -20°C for 20 min and
stained with 1% Alizarin Red S (Sigma-Aldrich) for 20 min
to measure calcified extracellular matrix. For adipogenic
differentiation, cells were induced by adipogenic induction
medium (Hyclone) which changed every 3-4 days. Three
weeks later, cells were fixed and stained with 0.3% Oil Red
O (Sigma-Aldrich) in isopropanol for 60 min. Chondro-
genic induction medium was used to induce chondrogenic
differentiation and changed every 3-4 days in the whole
process. After 28 days, cells were fixed and stained with
1% Alcian Blue 8-GX (Sigma-Aldrich) in 0.1 M HCl (pH
1.0) at 25°C for 12 h to detect sulfated glycosaminoglycans
deposited in matrix. Qualitative analysis was carried out
under an inverted microscope.
Neuronal induction of primary mesenchymal stem cells
and immortalized mesenchymal stem cells
Firstly, cells were cultured in complete DMEM/F12 con-
taining 1 μM all-trans- r e t i n o i ca c i d( A T R A )f o r2 4h r .
When cultured cells confluenced approximately 70-80%,
complete DMEM⁄ F12 was replaced by modified neuro-
nal induction medium (MNM) [DMEM/F12/1.6%
DMSO/160 μM butylated hydroxyanisole/20 mM KCl/
1.6 mM valproic acid/8 μM forskolin/0.8 μM
hydrocortisone/4 μg/ml insulin (all from Sigma)] to
induce neuronal differentiation for 24 hr.
Real-time PCR
Total RNA was extracted from cells with RNA isolation
Kit (Genemega Inc.) according to the manufacturer’s
manual. The RNA sample was treated with DNase I
(Invitrogen) to absolutely remove residual DNA. The first
strand cDNA was generated from purified RNA sample
using PrimeScript RT reagent Kit (TaKaRa) according to
the manufacturer’s instruction. Briefly, 2 μl5×P r i m e -
Script Buffer, 0.5 μl PrimeScript RT Enzyme Mix I, 0.5 μl
Oligo dT Primer, 0.5 μl Random 6 mers, and 500 ng total
mRNA were mixed together to a total volume of 10 μl
with RNA free water. The reverse transcriptase reaction
was performed as follows: 37°C for 15 min then 85°C for
5 sec. The cDNA products were diluted 10-fold as PCR
templates. Real-time PCR reaction was performed using
RealMasterMix kit (SYBR Green; TIANGEN BIOTECH)
and Bio-Rad Real-time PCR instrument. Reaction proto-
col was carried out as follows: 94°C × 20 sec, 55°C × 20
sec, 72°C × 20 sec, reading plate for 40 cycles. Data were
represented as Ct value and calculated to the fold change
using the ratio of the relative quantity of target gene to
the b-actin. Primer sequences for Nestin, neuron specific
enolase (NSE), microtubule-associated protein-2 (MAP-
2), glial cell line-derived neurotrophic factor (GDNF) and
b-actin were designed by using the Primer Primier 5 soft-
ware and listed as follows:
Nestin, forward: 5’-GGGCAAGTGGAACGTAGA-3’
reverse: 5’-TCCCACCGCTGTTGATTT-3’
NSE, forward: 5’-CTGTTTGCTGCTCAAGGTC-3’
reverse: 5’-TCCCACTACGAGGTCTGC-3’
MAP-2, forward: 5’-GTATCAGGAGACAGGGAG-
GAG-3’
reverse: 5’-GGGGTAGTAGGTGTTGAGGTG-3’
GDNF, forward: 5’-CACTGACTTGGGTTTGGG-3’
reverse: 5’-TCACTTGTTAGCCTTCTACTTC-3’
b-actin, forward: 5’-TTTGAGACCTTCAACACCCC-3’
reverse: 5’-GGATGGCATGAGGGAGC-3’
Immunofluorescence staining
Immunofluorescence staining was performed as
described before [24]. Briefly, cells were fixed with
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PBS. After blocked 1 hr with 5% BSA, the fixed cells
were incubated with Nestin, neuron specific enolase
(NSE), microtubule-associated protein-2 (MAP-2) (all
from Abcam) and glial cell line-derived neurotrophic
factor (GDNF) (Santa Cruz Biotechnology) primary anti-
body at 4°C overnight. After washed twice with PBS, all
samples were incubated with appropriate secondary
antibody conjugated to dylight 488 or 594 (Jackson
ImmunoResearch Laboratories) for 1 hr. And then, 4’6’-
diamidino-2-phenylindole dihydrochloride (DAPI)
(Sigma) was used to stain cell nucleus. At last, all sam-
ples were examined and imaged under a fluorescence
microscope (TE2000-S; Nikon). Control IgG of corre-
sponding primary antibodies were used as negative
controls.
Western Blotting
Western blotting was performed as described previously
[25]. Briefly, total protein was extracted by specific
extraction kit (Bioteke Co. Ltd.). Protein concentrations
of different samples were determined by using the BCA
protein assay kit (Bioteke Co. Ltd.) and enzyme-labelling
measuring instrument (Thermo Fisher Scientific). All
protein samples were denatured by boiling and loaded
onto a 10% SDS-polyacrylamide gel (Beyotime) with
approximately 30 μg total proteins per lane. After elec-
trophoretic separation, proteins were transferred to a
polyvinylidene fluoride membrane (Millipore). After
rinsed twice by tris buffered saline with tween-20
(TBST) (5 min per time), the membrane was blocked
with 5% skimmed milk in TBST at 37°C for 1 h and
probed with anti-NSE (Abcam) and anti-b-actin (Santa
Cruz Biotechnology) primary antibodies at 4°C overnight
then incubated with respective secondary antibody con-
jugated with horseradish peroxidase (Santa Cruz Bio-
technology) at room temperature for 1 hr. The
membrane was developed with an enhanced chemilumi-
nescent kit (TIANGEN) and photographed by ECL Ima-
ging System (Syngene GBOX, UK).
Electrophysiological recordings
Resting membrane potential of cells was recorded using
the whole-cell patch clamp technique at room tempera-
ture according to the methods described previously [26].
Cells were seeded on 8 × 8-mm glass coverslips and
then cultured in complete DMEM⁄ F12 or induced by
MNM for 24 h before electrophysiology recording. Cov-
erslips were placed in an acrylic chamber (RC-26L) of
inverted microscope (TE-2000U, Nikon, Japan), then
perfused at 1.0-1.8 ml/min. Borosilicate glass capillaries
(TW150F-4, WPI, FL, USA) were calcined and stretched
into approximately 1 μm tip diameter patch electrodes.
Pipette resistances approximately ranged from 3 to 4 m
Ω. Electrodes were filled with internal solution contain-
ing (in mmol/L) 140 KF, 10 4-(2-hydroxyethyl)-1-pipera-
zineethanesulfonic acid (HEPES), and 10 ethylene glycol
tetraacetic acid (EGTA) and 5 adenosine triphosphate
(ATP)-Na2. Internal solutions were adjusted to pH 7.2
with CsOH. The external bath solution contained (in
mM) 140 NaCl, 5 KCl, 1.8 CaCl2, 1 MgCl2·6H2O, 10
D-glucose, and 10 HEPES were regulated to pH 7.4 with
NaOH. After the formation of a gigaohm seal by nega-
tive pressure suction on single cell using patch electro-
des, the whole-cell recording was established. Data
acquisition was achieved by using Multiclamp 700B
amplifier (Axon Instruments) and Digidata 1322 inter-
face (Axon Instruments).
Animals
Animal experiment protocols were approved by
Chongqing Medical University Institutional Animal Care
and Use committee. Sprague Dawley (SD) rats and nude
mice were gained from the Experimental Animal Centre
of Chongqing Medical University [certificate: SCXK (Yu)
2007~0001]. All rats and mice were housed under speci-
fied pathogens free (SPF) level laboratory conditions.
Rats and mice were maintained under optimal condi-
tions of hygiene, temperature, humidity, photoperiods
(12L: 12D) with food and water available ad libitum.
Tumorigenicity detection of primary mesenchymal stem
cells and immortalized mesenchymal stem cells
Nude mice were used to detect tumorigenicity of pri-
mary MSCs and IMSCs. Cells suspended in PBS were
transplanted into nude mice by subcutaneous injection.
Rat yolk sac tumor cells (L2RYC) were used as positive
control. Twenty four nude mice aging 8 weeks were
divided into three groups equally. One group nude mice
were subcutaneously injected primary MSCs (injected in
the left front and rear notum of nude mice) and IMSCs
(injected in the right front and rear notum of nude
mice). Second group nude mice were subcutaneously
injected rat yolk sac tumor cells (injected in the left
front and rear notum of nude mice) and primary MSCs
(injected in the right front and rear notum of nude
mice). Third group nude mice were subcutaneously
injected rat yolk sac tumor cells (injected in the left
f r o n ta n dr e a rn o t u mo fn u d em i c e )a n dI M S C s
(injected in the right front and rear notum of nude
mice). 1 × 10
6 cells were transplanted at each injection
site. Six weeks later, all nude mice were executed by
CO2 asphyxiation. Pictures of nude mice and gross spe-
cimen were taken using digital camera. Tumor nodules
were removed and fixed in 4% paraformaldehyde solu-
tion. After fixation and paraffin embedded, tissues were
cut into 5 μm thick sections. These tissue sections were
deparaffinized in xylene andr e h y d r a t e du s i n gg r a d e d
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hematoxylin and eosin successively. And then, they were
dehydrated and differentiated by ethanol. After dropping
Canada balsam on the sections, coverslips were covered
to seal them. Histological images were photographed
with a microscope (Nikon ECLIPSE 55i, Japan) and a
digital camera (LEIKA DFC 420C, Germany).
Hypoxic-ischemic brain-damage (HIBD) rat model
Neonatal hypoxic-ischemic brain damage model was
established as previous methods [27]. Briefly, the left
carotid artery of seven day postnatal SD rat was isolated
and ligated doubly. After 2 hours recovery with their
mothers, offsprings were placed into a transparent plas-
tic container which was ventilated with a constant flow
of humidified mixture of 8%o x y g e na n d9 2 %n i t r o g e n
for 2.5 hr. The container was placed in a 37°C water
bath for maintaining proper temperature. 24 hr after
hypoxia-ischemia, the offsprings were randomly divided
into 3 groups and transfused with 1-2 × 10
6 MSCs or
IMSCs in 100 μL of PBS by intraperitoneal injection.
Morris Water Maze test
At age of five weeks, 15 rats of each group were
received Morris water maze [28] test training to evaluate
their spatial learning and memory abilities. Morris water
maze test system (MWM SLY-WMS 2.0, China) was
u s e di nt h et e s t .T h em a z ew a sa1 . 5 - m - d i a mc i r c u l a r
pool filled with clear tap water at a temperature of 20 ±
0.5°C. A 10-cm-diam platform was placed in the III
quadrant 1 cm up or submerged 2 cm below the water
surface during visible test and invisible test. The proce-
dure consisted of 1 d of visible platform tests and fol-
lowed by 4 d of hidden platform tests, plus a probe trial
24 h after the last hidden platform test. In the visible
platform test and the hidden platform tests, rats were
tested for 4 contiguous trials in respective four quad-
rants per day; with an intertrial interval of 30 min.
Track of animal movement was recorded in the test. To
assess memory consolidation, a probe trial was per-
formed after the last hidden platform test. In this trial,
the platform was removed from the pool and the pass
times in target area were recorded within 60 s.
Shuttle Box test
At 35 days of age, 15 rats of each group were subjected
to a shuttle box test (KE ZH-DSX2, China), comprising
two compartments (50 × 20 × 25 cm). Experiments con-
taining training and formal testing were performed to
train the rats that consistent response to the electric
shock. For each trial, a 10 sec conditioning stimulus
(CS), comprising a buzzer and a light, was followed by
10 sec of unconditioned stimulus, comprising the CS
plus a 0.6 mA electric current to the grid floor. All rats
were trained for 1 day, 20 times a day, at intervals of 2-
3 min. Formal test were operated at 2-5 d, 20 condition-
ing trials, separated by 2-3 min inter-trial intervals. If
the rat run into the safe chamber within 10 s after
sound and light, it was recorded for the active avoidance
response, or fled into the safe chamber after got electric
shocks, it was recorded for passive avoidance response;
still not, it was record for no avoidance response. We
analyzed the proportion of active avoidance response
and no avoidance response, respectively.
Statistical analysis
Results were expressed as Means ± S.E.M. if not indi-
cated otherwise. The data were analyzed using SPSS
18.0 software. Statistical analyses were performed using
one-way analysis of variance (ANOVA) or student t test.
P ≤ 0.05 was considered statistically significant.
Results
Isolation and identification of rat primary mesenchymal
stem cells
Primary MSCs were isolated from 4 weeks old SD rats
and propagated in vitro successfully. MSCs adhered to
the surface of plastic culture dishes and exhibited a
spindle-shaped fibroblast-like morphology as cells
approached confluence (Figure 1A, B). Although there is
no specific marker, it is generally agreed that rat MSCs
a r ep o s i t i v ef o rC D 2 9 ,C D 4 4 ,C D 9 0a n dC D 1 0 6a n d
negative for CD34 and CD45. MSCs at passage 5 were
identified by flow cytometry to detect these cell makers.
As expected, more than 99% of the cells were CD29,
CD44, CD90 and CD106 positive (Figure 1E, F, G, H),
and vast majority of the cells were CD34 and CD45
negative (Figure 1C, D). These results were consistent
with previous studies [29,30], confirming that these cells
u s e di nt h ep r e s e n ts t u d yw e r ei n d e e dM S C sw i t h o u t
hematopoietic stem cells contamination.
Construction and identification of immortalized
mesenchymal stem cells
The retroviral vector SSR#69 that expresses SV40T anti-
gen and hygromycin resistant gene flanked with loxP
sites (Figure 2A) was used to construct IMSCs. The ret-
roviral vector SSR#69 can be reconstructed by site-spe-
cific Cre/loxP recombination to excise SV40T gene
(Figure 2A). Primary MSCs were infected with retrovirus
packaged SSR#69 for 3 days and selected with hygromy-
cin B for 14 days. And then, MSCs which expresses
SV40T and hygromycin resistant gene were obtained.
These IMSCs at passage 40 were not different from pri-
mary MSCs in morphology and also presented spindle-
shaped fibroblastic shape (Figure 2B, C). Western blot-
ing result revealed that SV40T was highly expressed in
IMSCs, but lost its expression after Cre/loxP mediated-
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Page 5 of 16Figure 1 Morphology and identification of rat primary mesenchymal stem cells (MSCs). A: Morphology of rat primary MSCs at passage 3
(Scale Bar = 100 μm). B: Cultured primary MSCs were stained with haematoxylin-eosin (HE) (Scale Bar = 100 μm). C-H: Primary MSCs (passage
five) were analysed by FACS to detect the expression of mesenchymal surface markers using monoclonal antibodies. (C) CD34-fluorescein
isothiocyanate (FITC) labeled; (D) CD45-Phycoerythrin (PE) labeled; (E) CD29-FITC labeled; (F) CD44-FITC labeled; (G) CD90-PE labeled; (H) CD106-
PE labeled.
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Page 6 of 16Figure 2 Construction, morphology and characteristics of rat immortalized mesenchymal stem cells (IMSCs). A: Schematic drawings of
the integrating component of retroviral vector SSR#69 for reversible immortalization. SSR#69 contains the hygromycin B resistance gene (Hyg R)
as a positive selectable marker and the herpes simplex virus thymidine kinase gene (HSV-TK) as a negative selectable marker. The SV40T, Hyg R
and HSV-TK genes are flanked by loxP sites. B: Morphology of rat IMSCs at 40 passage (Scale Bar = 100 μm). C: Cultured IMSCs were stained with
haematoxylin-eosin (HE) (Scale Bar = 100 μm). D: Western bloting was performed to determine the protein level of SV40T antigen in three
different kinds of MSCs. SV40T antigen expressed highly in IMSCs, however, it almost could not be detected in IMSCs after Cre-recombination.
MSCs did not express SV40T antigen.
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(Figure 2D). Flow cytometry results showed IMSCs were
positive for CD29 (99.81%), CD44 (99.96%), CD90
(99.84%) and CD106 (99.45%), and negative for CD34
(0.41%) and CD45 (4.27%) (Figure 3), indicating that
MSCs surface makers did not change after immortaliza-
tion. These data demonstrated that reversible IMSCs
were constructed successfully and had the similar mor-
phology and cell surface makers as primary MSCs.
Proliferation capacity and trilineage potential of
immortalized mesenchymal stem cells
To investigate whether immortalization by SV40T
affects proliferation and differentiation potential of
Figure 3 Identification of rat immortalized mesenchymal stem cells (IMSCs) by FACS. IMSCs were analysed by FACS to detect the
expression of mesenchymal surface markers using monoclonal antibodies. (A) CD34-fluorescein isothiocyanate (FITC) labeled; (B) CD45-
Phycoerythrin (PE) labeled; (C) CD29-FITC labeled; (D) CD44-FITC labeled; (E) CD90-PE labeled; (F) CD106-PE labeled.
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trilineage differentiation tests were performed. The
numbers of viable cells were counted at different time-
points. All cells number continuously increased as time
gradually went by, and arrived at peak at day 3. But it
decreased to a platform from day 3 to day 5 (Figure
4A). As cell growth curve presenting, the number of
viable IMSCs was significantly higher than that of pri-
mary MSCs from day 2 to 5 (p < 0.01). But the number
of reversed IMSCs was not statistically different from
that of primary MSCs from day 2 to 5 (p > 0.05). These
data indicated that proliferation capacity of IMSCs was
stronger than that of primary MSCs and could be
reversed.
We then further determined whether IMSCs are able
to maintain their mesodermal trilineage differentiation
potential after immortalized by SV40T. As shown in Fig-
ure 4B, both MSCs and IMSCs could be induced in
vitro to possess the typical characteristics of mature
osteocytes, adipocytes, and chondrocytes, indicating that
IMSCs maintain mesodermal trilineage potential even
through immortalized by SV40T.
Neuronal differentiation characteristics of immortalized
mesenchymal stem cells in vitro
Numerous studies have demonstrated that MSCs could
be induced to differentiate into neuronal cells in vitro
[31]. To investigate whether immortalization by SV40T
affects neuronal differentiation of MSCs, comparison
experiments about neuronal differentiation of primary
MSCs and IMSCs were performed in vitro.A ss h o w ni n
Figure 5A-D, the mRNA levels of neural-specific genes
including Nestin, NSE, MAP-2, and GDNF were signifi-
cantly increased by 2-10 times after induced by MNM
both in primary MSCs and IMSCs (P <0 . 0 0 1 ) .A n dt h e
fold increases of these neural-specific genes were not
significantly different (P > 0.05) between MNM-induced
primary MSCs and IMSCs (Figure 5E). These data indi-
cated that both primary MSCs and IMSCs could be
induced to neuronal cells in vitro and there was no dif-
ference in mRNA level of neural specific markers after
neuronal differentiation.
Next, immunofluorescence staining and western blot-
ting were also performed to detect the protein expres-
sion level of neural-specific makers. After induced by
MNM, both primary MSCs and IMSCs were changed
into neural-like cells presenting distinct neuronal
morphologies including simple bipolar, large and exten-
sively branched multipolar appearance (Figure 5F). Nes-
tin, NSE, MAP-2, and GDNF could hardly be detected
in both primary MSCs and IMSCs, but these neural-spe-
cific makers expressed intensely in neural-like cells
derived from both primary MSCs and IMSCs in vitro
(Figure 5F). And then, the protein expression level of
NSE during a 24 h span including 0, 6, 12, 18, and 24 h
time-point of MNM induction in both primary MSCs
and IMSCs were analyzed by western blotting. NSE
expression increased dramatically at 6 h post MNM
induction and continued to increase for up to 24 h. And
the growth trend was probably consistent in both pri-
mary MSCs and IMSCs after induced with MNM (Fig-
ure 5G).
Resting membrane potential (RMP), which refers to
the constant potential difference between inside and
outside of the unstimulated cell membrane, is the pre-
mise and foundation of neurons excitability. RMP in dif-
ferent types of cells was measured by using whole cell
patch clamp as a functional index. As shown in Figure
5H, both primary MSCs and IMSCs had low RMP (n =
8, -4.825 ± 1.12091 mV and -5.05714 ± 1.11484 mV; P
> 0.05). However, neural-like cells derived from both
primary MSCs and IMSCs were significantly hyperpolar-
ized with a RMP of -36.875 ± 8.13173 (n = 16, P <
0.001, MSCs + MNM vs. control MSCs) mV and
-39.2857 ± 6.84871 mV (n = 16, P <0 . 0 0 1 ,I M S C s+
MNM vs. control IMSCs), respectively. But there was
no difference in RMP between two groups. These data
indicated that IMSCs had the same potential to develop
into mature functional mature neurons as primary
MSCs.
Transplantation of immortalized mesenchymal stem cells
replaces MSCs to improves memory deficits in rat model
of neonatal hypoxic-ischemic brain damage
Transplantation experiments have demonstrated that
M S C st h e r a p yc o u l di m p r o v en eurological function in
animal models of Parkinson’s disease [32], stroke [33],
cerebral ischemia [34], and spinal cord injury [35]. The
functional recovery of the HIBD models after treatment
of primary MSCs and IMSCs transplantation was com-
pared by using Morris water maze and shuttle box tests.
Before IMSCs transplantation, we excluded its tumori-
genicity firstly. Primary MSCs, IMSCs and rat yolk sac
tumor cell lines (L2RYC) were subcutaneously inocu-
lated in nude mice, respectively. Six weeks later, tumori-
geneses of these cells were investigated. As shown in
Figure 6A and 6B, inoculated L2RYC performed peanut-
sized bumps in injection sites; however, both MSCs and
IMSCs had no bump formation in nude mice. And then
positive bumps were removed and stained by hematoxy-
lin-eosin. Many naïve morphology and atypia appear-
ance of microcystic structure, Schiller-Duvall body,
papillary and glomeruloid-like structures were observed
in the bump tissues (Figure 6C). These data indicated
that IMSCs were safe for transplantation therapy in vivo
as primary MSCs.
The Morris water maze tests were performed four
weeks after HIBD models received cells transplantation
Gong et al. Journal of Biomedical Science 2011, 18:87
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Page 9 of 16therapy. In the visible platform tests (D1), each group
exhibited similar escape latencies (P >0 . 0 5b yS t u d e n t ’s
t test; Figure 7A) and path lengths (P >0 . 0 5b yS t u -
dent’s t test; Figure 7B), which indicated that HIBD
treatment did not affect rat motility or vision. In the
hidden platform-swimming test (from D2 to D5), the
escape latencies and the path lengths of all groups
gradually reduced during test time. PBS group showed
significant decline compared with control group. The
escape latency from D2 to D5 of PBS group was longer
than that of control group rats (*, p < 0.01, PBS vs. con-
trol, by one-way ANOVA; Figure 7A). The PBS group
rats had to swim significantly longer distances to reach
the platform compared with control rats from D2 to D5
Figure 4 Proliferation capacity of three different kinds of MSCs and trilineage potential of IMSCs. A: Growth curve of three different kinds
of MSCs (primary MSCs, IMSCs, and IMSCs Cre T antigen). The number of viable cells gradually increased from D0 and attained peak at D3 in all
three kinds of MSCs. And then, viable cells number decreased sharply from D3 to D5. The viable cells number of IMSCs was significantly more
than another two kinds of MSCs from D2 to D5 (*, p < 0.01 by one-way ANOVA). The tendence of cell growth of IMSCs was reversible with cre
recombination. B: Osteocytes, chondrocytes and adipocytes were induced from primary MSCs and IMSCs. IMSCs displayed the same mesodermal
trilineage differentiation potential as MSCs (Scale Bar = 20 μm).
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Page 10 of 16Figure 5 IMSCs exhibit the same neuronal differentiation capacity as primary MSCs in vitro. A-D: Transcriptional expression of Nestin, NSE,
MAP-2, GDNF during neuronal differentiation of MSCs and IMSCs. The transcriptional expression of genes was determined by measuring their
mRNA levels with real-time PCR. Treatment of primary MSCs and IMSCs with MNM resulted in a dramatic increase in the mRNA levels (*, P <
0.001 by Student’s t test). Real-time PCR results were confirmed in at least three batches of independent experiments with b-actin normalization.
E: Fold increase of Nestin, NSE, MAP-2, and GDNF mRNA expression levels after induced by MNM. The mRNA expression levels of neural markers
in both MSCs and IMSCs increased about 8, 10, 5 and 3 fold increases after treated with MNM, respectively (P > 0.05 by Student’s t test). F:
Immunofluorescence staining of Nestin, NSE, MAP-2, and GDNF during neuronal differentiation of MSCs and IMSCs (Scale bar = 20 μm). G:
Expression of NSE during a 24 hr span including 0, 6, 12, 18, and 24 hr time-point of MNM induction in both primary MSCs and IMSCs were
analyzed by western blotting. Equal loading of the samples was confirmed by comparable levels of b-actin detected in each lane. H: Resting
membrane potential was measured by using whole cell patch clamp. The values represented Means ± S.E.M. (*, p < 0.001, MSCs vs. MSCs +
MNM;
&, p < 0.001, IMSCs vs. IMSCs + MNM; p > 0.05, MSCs + MNM vs. IMSCs + MNM, by Student’s t test).
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Page 11 of 16(*, p < 0.01, PBS vs. control, by one-way ANOVA; Fig-
ure 7B). However, the escape latency and path length
became shorter after primary MSCs or IMSCs therapy
(
&, p < 0.05, MSCs/IMSCs vs. PBS, by one-way
ANOVA; Figure 7A, B). Further more, the MSCs group
and IMSCs group had similar escape latencies and paths
length (p > 0.05 by one-way ANOVA; Figure 7A, B). In
the probe trial on the last day of testing, the platform
was removed. As shown in Figure 6F, compared with
control group, there was significantly less number of the
PBS group rats traveled through the place where the
hidden platform was previously placed (*, P <0 . 0 1 ,P B S
vs. control, by Student’s t test; Figure 7C). However, the
passing times significantly increased after primary MSCs
or IMSCs therapy (
&, P < 0.05, MSCs/IMSCs vs. PBS, by
Student’s t test; Figure 7C). And the passing times
between two cell therapy groups had no statistic differ-
ence (P > 0.05 by Student’s t t e s t ;F i g u r e7 C ) .F u r t h e r ,
we examined learning ability through the shuttle box
test. We found that HIBD rats received primary MSCs
or IMSCs therapy showed an increased active avoidance
response rate (AARR) on the 3
rd,4
th and 5
th test day (
&,
P < 0.05, MSCs/IMSCs vs. PBS, by one-way ANOVA;
Figure 7D) and decreased no avoidance response rate
(NARR) on the 2
nd and 3
rd test day (
&,P<0 . 0 5 ,M S C s /
IMSCs vs. PBS, by one-way ANOVA; Figure 7E). In
addition, both AARR and NARR between two cell ther-
apy groups had no statistic difference (p > 0.05 by one-
w a yA N O V A ;F i g u r e7 D ,E ) .T a k e nt o g e t h e r ,t h e s e
above data indicated that IMSCs were the same as pri-
mary MSCs to be used in repairing brain injury with
improved learning ability and spatial memory.
Disscussion
Aging has been defined as ‘’the sum of primary restric-
tions in regenerative mechanisms of multicellular organ-
isms’’ by Sames and Stolzing [36]. Cellular senescence is
a complex phenotype that entails changes in both func-
tion and replicative capacity [37]. Because of its finite
replicate capacity, MSCs will become senescent after
multiple passages. The morphology and multilineage dif-
ferentiation capacity of senescent MSCs are different
from young MSCs. Since a tremendous number of cells
are needed for a clinical application, MSCs must be
expanded by consecutive passages to provide enough
cell sources. A significant increase in the fraction of flat-
tened/hypertrophic and multinucleated MSCs over con-
secutive passages [38,39] seriously affects its application
value and therapeutic effects for cell-based regenerative
medicine and tissue engineering. Simian virus 40 large
T (SV40T) antigen which is derived from polyomavirus
SV40 is capable of perturbing the retinoblastoma (pRB)
and p53 tumor suppressor proteins and interfering with
one or more specific cyclins [40]. It causes the cells to
leave G1 phase and enter into S phase, which promotes
DNA replication and cell proliferation. SV40T was used
as a prototypical immortalizing gene [19].
Here, we show that an immortalized mesenchymal stem
cells (IMSCs) line has been constructed by infected with
retrovirus SSR#69 expressing SV40T. Consistent with pre-
vious reports, the morphology [41] and cell surface mar-
kers [42,43] of IMSCs did not change after consecutive 40
passages. Immortalization by SV40T prevented MSCs
from senescence over consecutive passages, meanwhile
maintained its surface marks. The retroviral vector
SSR#69 is characterized by that can be reconstructed by
Figure 6 Tumorigenicity detection of IMSCs. A: Inoculated rat
yolk sac tumor cell lines (L2RYC) performed peanut-sized bumps in
injection sites (the left front and rear notum of nude mice), but no
bump generated in IMSCs injection sites (the right front and rear
notum of nude mice). B: No bump generated in both primary MSCs
injection sites (the left front and rear notum of nude mice) and
IMSCs injection sites (the right front and rear notum of nude mice).
C: Haematoxylin-eosin (HE) staining for tumor nodules derived from
L2RYC injection sites (Scale bar = 100 μm).
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Page 12 of 16site-specific Cre/loxP recombination to excise SV40T (Fig-
ure 2A). We revealed that immortalization could be
reversed after Cre/loxP mediated-excision (Figure 2D).
This characteristic of IMSCs ensures the safety of its clini-
cal application. Several independent reports have shown
that cells proliferation capacity can be enhanced by SV40T
[44-46]. We found that proliferation capacity of IMSCs
was significantly stronger than that of primary MSCs. The
number of IMSCs can be expanded rapidly by limited pas-
sages in the short term to obtain gigantic number of cells
and content the needs of experimental study both in vitro
and in vivo. As previous studies reported that cells pre-
served their differentiation capacity after immortalization
[47-51]; IMSCs in the present study also retain multiline-
age differentiation capacity including osteogenesis, adipo-
genesis, chondrogenesis and neurogenesis. In short,
IMSCs not only retained their features of primary MSCs
but also possessed higher proliferation capacity and anti-
senescence ability.
The ability of MSCs to differentiate into functional
neurons has been demonstrated by many in vitro studies
[52], and further confirmed by cell transplantation
experiments in brain injury and neurodegenerative dis-
eases animal models [53,54]. Our previous studies have
also supported those results [9,10]. Can IMSCs as an
alternative to MSCs be used in neuronal differentiation
research in vitro and transplantation experiments to
improve neurological function of brain injury animal
models? In the present study, we showed that IMSCs
could definitely be induced to differentiate into neuronal
cells in vitro. Meanwhile, neural-like cells derived from
IMSCs had similar expressions of neural-specific genes,
protein expression patterns and resting membrane
potential (RMP) compared with their counterparts
derived from primary MSCs. Consistent with primary
MSCs, IMSCs could be induced into neuronal differen-
tiation and had the same potential to develop into
mature functional neurons in vitro.A l t h o u g hp r e v i o u s
Figure 7 Therapeutic effects of primary MSCs and IMSCs in rat model of neonatal HIBD by cell transplantation. A: In hidden platform
tests (from D2 to D5), the escape latency of PBS group (*, p < 0.01, PBS vs. control) became shorter after primary MSCs or IMSCs therapy (
&, p <
0.05, MSCs/IMSCs vs. PBS). There were no statistical difference between primary MSCs group and IMSCs group (p > 0.05). B: In hidden platform
tests (from D2 to D5), the path lengths of PBS group (*, p < 0.01, PBS vs. control) became shorter after primary MSCs or IMSCs therapy (
&, p <
0.05, MSCs/IMSCs vs. PBS). There were no statistical difference between primary MSCs group and IMSCs group (p > 0.05). C: In the probe trial on
the sixth day, the passing times of PBS group (*, P < 0.01, PBS vs. control) significantly increased after primary MSCs or IMSCs therapy (
&, P <
0.05, MSCs/IMSCs vs. PBS). And the MSCs group and IMSCs group had similar passing times (P > 0.05). D: The active avoidance response rate
(AARR) of the MSCs group and IMSCs group were significantly higher than that of PBS group on the 3rd, 4th and 5th test day (
&, P < 0.05,
MSCs/IMSCs vs. PBS). E: The no avoidance response rate (NARR) of MSCs group and IMSCs group were significantly lower than that of PBS group
on the 2
nd and 3
rd test day (
&, P < 0.05, MSCs/IMSCs vs. PBS).
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acute liver failure in animal models without tumorigen-
esis [55-57], SV40T mediated cells might be closely
related to oncogenesis [58,59]. Before IMSCs transplan-
tation in HIBD models, we firstly detected its tumori-
genicity firstly. We found that there was no tumor
formation in nude mice at 6-week after subcutaneously
inoculated with IMSCs, indicating that IMSCs were safe
for transplantation therapy in vivo.A n dt h e n ,w et r a n s -
planted IMSCs into HIBD models to investigate its
impact on neurological function. The Morris water
maze (MWM) and shuttle box are frequently used
laboratory tools for detecting learning ability and spatial
memory of animal models [60,61]. In animal behavioral
tests, we demonstrated that IMSCs possessed the same
effect as primary MSCs in improving the cognitive func-
tion in HIBD rats. Before we transplanted MSCs into
HIBD rats, we have verified that GFP labeled primary
MSCs and IMSCs transplanted by intraperitoneal injec-
tion could migrate and locate in the brain region (data
not shown). The neurological function recovery of
HIBD rats might be closely related to the transdifferen-
tiation or immuno-regulation effects of MSCs. Our stu-
dies suggested that IMSCs was indeed a great alternative
for MSCs in neuronal differentiation research in vitro
and transplantation experiments in brain injury animal
models.
Conclusion
In summary, we have established an immortalized
mesenchymal stem cells line with the characteristic of
reversible immortalization. IMSCs possessed higher pro-
liferation capacity and anti-senescence ability in addition
to fundamental features of primary MSCs. IMSCs were
proved to be a potential and valuable alternative to
MSCs in neuronal differentiation and neuroregeneration
associated studies.
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